AU4419293A - Pharmaceutical compositions having antiaggregant and vasodilating activities - Google Patents

Pharmaceutical compositions having antiaggregant and vasodilating activities

Info

Publication number
AU4419293A
AU4419293A AU44192/93A AU4419293A AU4419293A AU 4419293 A AU4419293 A AU 4419293A AU 44192/93 A AU44192/93 A AU 44192/93A AU 4419293 A AU4419293 A AU 4419293A AU 4419293 A AU4419293 A AU 4419293A
Authority
AU
Australia
Prior art keywords
antiaggregant
pharmaceutical compositions
vasodilating activities
vasodilating
activities
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44192/93A
Other languages
English (en)
Inventor
Stefano Bongrani
Paolo Chiesi
Maurizio Civelli
Giancarlo Folco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Publication of AU4419293A publication Critical patent/AU4419293A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/081,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU44192/93A 1992-07-03 1993-06-18 Pharmaceutical compositions having antiaggregant and vasodilating activities Abandoned AU4419293A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI92A1629 1992-07-03
ITMI921629A IT1255207B (it) 1992-07-03 1992-07-03 Composizioni farmaceutuche ad attivita' antiaggregante e vasodilatatrice
PCT/EP1993/001559 WO1994001422A1 (en) 1992-07-03 1993-06-18 Pharmaceutical compositions having antiaggregant and vasodilating activities

Publications (1)

Publication Number Publication Date
AU4419293A true AU4419293A (en) 1994-01-31

Family

ID=11363616

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44192/93A Abandoned AU4419293A (en) 1992-07-03 1993-06-18 Pharmaceutical compositions having antiaggregant and vasodilating activities

Country Status (3)

Country Link
AU (1) AU4419293A (it)
IT (1) IT1255207B (it)
WO (1) WO1994001422A1 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4220264A1 (de) * 1992-06-20 1993-12-23 Cassella Ag Phenyl-1,2,5-oxadiazol-carbonamid-2-oxide
DE4417705A1 (de) * 1994-05-20 1995-11-23 Cassella Ag Substituierte Furoxane
DE19624990A1 (de) * 1996-06-22 1998-01-08 Gluesenkamp Karl Heinz Dr Verfahren zur chemischen kontrollierten Modifizierung von Oberflächen sowie von Acyl- und/oder Hydroxyl-Gruppen tragenden Polymeren
JP2008543863A (ja) 2005-06-15 2008-12-04 ハイドラ バイオサイエンシズ インコーポレイテッド 精子の運動亢進のモジュレーター及びその利用
EP1915157A4 (en) 2005-08-02 2010-09-01 Nicox Sa NICKEL OXYGENIZING ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND USE PROCESSES
EP2007705A4 (en) 2006-03-29 2011-09-07 Nicox Sa NITROGEN MONOXIDE REINFORCING PROSTAGLANDIN COMPOUNDS, COMPOSITION AND APPLICATION PROCESS
JP6773948B2 (ja) * 2015-01-14 2020-10-21 亮介 松原 フロキサン化合物及びその製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3012862A1 (de) * 1980-04-02 1981-10-08 Cassella Ag, 6000 Frankfurt Substituierte 1,2,5-oxdiazol-2-oxide als pharmazeutische wirkstoffe, ihre verwendung und sie enthaltende arzneimittel

Also Published As

Publication number Publication date
WO1994001422A1 (en) 1994-01-20
ITMI921629A0 (it) 1992-07-03
ITMI921629A1 (it) 1994-01-03
IT1255207B (it) 1995-10-20

Similar Documents

Publication Publication Date Title
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
AU7414694A (en) Pharmaceutical compositions and usages
IL106431A0 (en) Aminediol derivatives and pharmaceutical compositions containing the same
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
AU2157192A (en) 4-aminoquinolines and pharmaceutical compositions thereof
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
AU663637B2 (en) Solutions and their preparation
AU4484997A (en) Compositions containing cobalamin and amino acids
AU1396395A (en) Farnesyl derivatives and pharmaceutical compositions containing them
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
GB2271059B (en) Pharmaceutical compositions comprising aconitane derivatives and tetrahydroprotoberberine derivatives.
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
ZA967800B (en) Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
AU5067193A (en) Pyranoquinolines and their use as pharmaceuticals
AU4100593A (en) Iminoalcohol-oxazolidine mixtures and their use
AU4419293A (en) Pharmaceutical compositions having antiaggregant and vasodilating activities
AU3465393A (en) Pharmaceutic composition and its use
AU5883794A (en) Diazepin derivatives and antiviral compositions
AU5847694A (en) Chlorofluoroether compositions and preparation thereof
IL115982A0 (en) Cyclolignan derivatives and pharmaceutical compositions containing the same
AU7318994A (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them
IL117618A0 (en) Diphenylmethyl-azetidinone derivatives and pharmaceutical compositions containing the same
AU3533095A (en) Arylthiadiazole derivative and antiviral agent containing the same